Nine people reported fever, chills, chest pain or vomiting after receiving compounded injections that a Houston pharmacy has now recalled nationwide. Centric Compounding is pulling six lots of glutathione, Myer’s Cocktail and Tri-Immune Boost, injectables sold to support immunity, fatigue and general wellness, after the glutathione raw ingredient used to make them was found to contain elevated levels of endotoxin. The vials went to patients by home delivery and to prescribers across the country.
What failed, and where in the chain
Centric Compounding LLC issued its announcement on 9 September 2026 and the FDA published it on 13 September. Six lots are affected: three of glutathione 200 mg/mL in 30 mL multidose vials, two of Myer’s Cocktail in 30 mL vials, and one of Tri-Immune Boost in 30 mL vials. The company traced the problem to the active pharmaceutical ingredient it had purchased, saying all three products were compounded with a glutathione ingredient that carried elevated endotoxin levels.
Endotoxin is the point worth understanding, because it is not the same as contamination with live bacteria. It is a fragment of the outer wall of certain bacteria, and it survives the sterilisation that kills the organisms themselves. A vial can therefore pass a sterility test, contain nothing living, and still provoke a strong inflammatory response when it is injected. The FDA’s risk statement says there is a reasonable probability that injectable products with elevated endotoxin could cause significant medical events including fevers, low blood pressure, inflammatory reactions, anaphylactic shock and death. The nine reports the company received, of fever, chills, chest pain, nausea and vomiting, headache and malaise, are consistent with that pattern.
Two details compound the exposure. These are multidose vials, so a single affected vial is drawn from repeatedly, either for one person over several weeks or for several people. And the timing is poor: five of the six recalled lots had already passed their beyond-use date by the day the FDA published the notice, with those dates running from 7 August to 25 September 2026. Most of the product in question had therefore been used before anyone was told about it. The company is notifying distributors and customers by email and arranging replacements, and says the recall was conducted with the FDA’s knowledge.
What it means if you buy injectables by mail
The failure here was not a dirty room or a lapse in technique at the pharmacy. It arrived in the raw material, already present in the powder before anyone drew it into a syringe. That matters for anyone buying compounded injectables online, because it is the one part of the chain a customer can never inspect. A vial can be held up to the light and checked for cloudiness or particles; endotoxin is invisible and detectable only by a laboratory assay somebody else has to run and pass on trust.
That structural point extends well beyond wellness drips. The same ingredient-sourcing question sits underneath the much larger market in compounded GLP-1 injections shipped from telehealth pharmacies: a finished vial can be no better than the powder it was made from, and the buyer sees neither. Products marketed for immunity, energy and recovery tend to be bought on the assumption that the worst case is that they do nothing. A recall with nine symptomatic reports attached is a reminder that an injection carries risks a capsule does not, whatever the claims on the label.
A good deal is still not public. The notice does not name the supplier of the contaminated glutathione ingredient, and does not say whether other compounding pharmacies bought from the same batch, which is the question that determines whether this recall is the whole story or the first part of it. It does not say how many vials were distributed or how many patients received them. The nine reports are symptoms reported to the company rather than confirmed endotoxin reactions; no causality assessment has been published, and no FDA inspection findings have been released.
Sources: Centric Compounding Issues Nationwide Recall of Glutathione, Myer’s Cocktail, and Tri-Immune Boost Due to Elevated Endotoxin Levels, US Food and Drug Administration, company announcement 9 September 2026, published 13 September 2026.
